Search clinical trials for: Sodium Enoxaparin clexane

Total 10915 results

Biocad

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis

Russian Federation
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Venous Thromboembolism

Brazil
Rovi Pharmaceuticals Laboratories
PRA Health Sciences

Completed

Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

Healthy
Tel-Aviv Sourasky Medical Center

Unknown

Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity

Obesity

Israel
Venus Remedies Limited

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy

India
University of Oulu
University of Helsinki

Unknown

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Intracerebral Hemorrhage

Finland
Chemi S.p.A.

Completed

A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions

Clexane is Administered to Healthy Volunteers

United Kingdom
The Egyptian IVF-ET Center

Completed

Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)

Infertility

Egypt
Peking Union Medical College Hospital

Completed

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) (OPTIENOX-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
University of Sao Paulo General Hospital

Completed

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Venous Thrombosis | Deep Vein Thrombosis | Pulmonary Embolism | Perioperative/Postoperative Complications | Thrombophilia Associated With Pregnancy | Other Specified Risk Factors in Pregnancy

Brazil
Mohamed Sayed Abdelhafez

Completed

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Recurrent Miscarriage | Antiphospholipid Syndrome

Egypt
Shiraz University of Medical Sciences

Unknown

Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke

Embolic Stroke

Iran, Islamic Republic of
Sarah Sabry Hashem

Completed

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

Mitral Valve Disease

Egypt
French Cardiology Society

Completed

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

Renal Failure | Acute Coronary Syndrome

France
Western Galilee Hospital-Nahariya

Completed

Enoxaparin as Treatment for Vulvodynia

Vulvodynia

Israel
University Hospital, Ghent

Completed

Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency (ClotPara)

Bleeding | Coagulation

Belgium
PharmaDiall Ltd.

Completed

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

COVID-19 | Venous Thromboembolism

Russian Federation
Chemi S.p.A.

Completed

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Enoxaparin Sodium is Administered to Healthy Volunteers

United Kingdom
Indonesia University
PT Metiska Farma

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin

Indonesia
V.K.V. American Hospital, Istanbul

Completed

Low Molecular Weight Heparin in Recurrent Implantation Failure

Infertility | Recurrent Implantation Failure | Fertilization in Vitro

Turkey
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
Oregon Health and Science University

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events

United States
Sanofi

Completed

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Venous Thromboembolism

France, Russian Federation, Spain, Italy, Argentina, Belgium, Brazil, Canada, Colombia, Germany, Israel, Mexico, Poland, United States, Australia, Austria, India, South Africa, United Kingdom, Tunisia
Sanofi

Completed

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Myocardial Infarction | Acute ST-Segment Elevation

Canada, Brazil, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Slovakia, Belgium, Mexico, Uruguay, Argentina, Croatia, Austr... and more
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Ain Shams University

Completed

The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

Unexplained Infertility
Monash Medical Centre
Middlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland... and other collaborators

Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER)

Venous Thrombosis | Pulmonary Embolism

Australia, New Zealand
Melbourne Health
Sanofi; National Heart Foundation, Australia

Terminated

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Deep Vein Thrombosis

Australia
GlycoMimetics Incorporated
University of Michigan

Completed

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Healthy Volunteers

United States
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Radial Artery Occlusion

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
GlycoMimetics Incorporated
University of Michigan

Terminated

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Deep Venous Thrombosis

United States
ASST Fatebenefratelli Sacco
Massimo Arquati; Riccardo Colombo; Umberto Russo; Manuela Nebuloni; Spinello Antinori

Completed

Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 (EMOS-COVID)

Covid19 | Thrombosis

Italy
HaEmek Medical Center, Israel

Completed

anti10a Levels in Women Treated With LMWH in the Postpartum Period

Venous Thromboembolism

Israel
Thrombosis Research Institute
Sanofi

Terminated

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients (ETHIC)

COVID-19

Australia, Belgium, South Africa
CONKO-Studiengruppe

Completed

Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer

Pancreatic Cancer

Germany
Oregon Health and Science University
National Trauma Research Institute; Medical Research Foundation, Oregon

Completed

Thrombelastography Based Dosing of Enoxaparin

Thromboembolic Complications

United States
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
University of Utah
University of Michigan

Completed

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Surgery | Venous Thromboembolism | Deep Venous Thrombosis

United States
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
Sanofi

Completed

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery (TREK)

Venous Thromboembolism

Poland, Romania, Russian Federation, Portugal, Sweden, Turkey, Bulgaria, Malaysia, Philippines, Taiwan, Mexico, Argentina, Denmark, Finland, Norway, Colombia, Chile, Thailand, Greece
Wake Forest University Health Sciences

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism

United States
Oregon Health and Science University

Terminated

Below Knee DVT Study

Deep Vein Thrombosis (DVT) | Blood Clots

United States
Loyola University

Withdrawn

Timing of VTE Prophylaxis in TBI

TBI (Traumatic Brain Injury) | VTE (Venous Thromboembolism)

United States
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (CRETE)

Deep Venous Thrombosis

United States
TeaRx LLC

Completed

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Total Knee Replacement

Russian Federation
Bayer

Completed

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Venous Thromboembolism

United States, Canada
Lebanese American University

Completed

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Renal Impairment | Venous Thromboembolism

Lebanon
University of Utah

Completed

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States

Search clinical trials for: Sodium Enoxaparin clexane

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations